- Home
- TRT vs COYA Comparison
TRT vs COYA Comparison
Compare TRT & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRT | COYA |
|---|---|---|
| Founded | 1958 | 2020 |
| Country | United States | United States |
| Employees | N/A | 8 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.1M | 110.0M |
| IPO Year | 1995 | 2022 |
Fundamental Metrics
Financial Performance| Metric | TRT | COYA |
|---|---|---|
| Price | $11.46 | $4.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $15.80 |
| AVG Volume (30 Days) | ★ 299.0K | 166.6K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $32,462,000.00 | $7,945,753.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $763.10 |
| P/E Ratio | $584.00 | ★ N/A |
| Revenue Growth | N/A | ★ 123.57 |
| 52 Week Low | $4.42 | $3.71 |
| 52 Week High | $21.38 | $7.75 |
Technical Indicators
Market Signals| Indicator | TRT | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 55.13 | 54.62 |
| Support Level | $9.15 | $4.45 |
| Resistance Level | $11.79 | $5.18 |
| Average True Range (ATR) | 0.83 | 0.23 |
| MACD | 0.21 | 0.07 |
| Stochastic Oscillator | 80.00 | 95.98 |
Price Performance
Historical ComparisonAbout TRT Trio-Tech International
Trio-Tech International is a provider of reliability test equipment and services to the semiconductor and other industries. Its customers are from automotive electronics, industrial electronics, computing and data storage, consumer electronics, and communication markets. The company operated its business in two segments: Semiconductor Back-end Solutions and Industrial Electronics. Geographically, the company operates in the United States (U.S), Singapore, Malaysia, Thailand and China.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.